Open Demat
Be a Partner
Samadhan
Install App
Install App

157

508869

APOLLOHOSP

img img img img
Compare to down-arrow
View down-arrow
Display down-arrow
Studies down-arrow
No Data Available

APOLLO HOSPITALS ENTER. L Share Price Update

As of the latest trading session, APOLLO HOSPITALS ENTER. L is trading at ₹8089, down by ₹-19.50 or -0.24% from its previous close. The stock has moved between ₹7816.00 and ₹8100.00 today. Over the past year, the stock has delivered a return of 17.25%. In the last month, it has returned 4.79%.

APOLLO HOSPITALS ENTER. L performance

Today’s low Today’s high
₹ 7816.00 ₹ 8100.00
₹ 8045.00
52 week low 52 week high
₹ 6696.50 ₹ 8443.00
₹ 8045.00
Open Price ₹ 7816.00
Prev. Close ₹ 8108.50
Volume (Shares) 373680.00
Total traded value ₹ 30062.55
Upper Circuit ₹ 8919.00
Lower Circuit ₹ 7298.00
info

Investment Returns

Over 1 Month 4.79% Over 3 Months 4.06% Over 6 Months 11.26% Over 1 Year 17.25%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

APOLLO HOSPITALS ENTER. L fundamentals


  • Market cap (Cr) 1,15,674.80
  • P/E Ratio (TTM) 78.02
  • Beta 0.67
  • Book Value / share 692.92
  • Return on equity 15.77%
  • EPS (TTM) 104.41
  • Dividend yield 0.25%
  • Net profit/quarter (Cr) 382.40
info icon alternate text
  • Market cap (Cr) 1,15,602.90
  • P/E Ratio (TTM) 78.02
  • Beta 0.63
  • Book Value / share 692.92
  • Return on equity 15.77%
  • EPS (TTM) 104.41
  • Dividend yield 0.25%
  • Net profit/quarter (Cr) 382.40
info icon alternate text

APOLLO HOSPITALS ENTER. L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 2438.50
Operating Expense 2034.40
Net Profit 382.40
Net Profit Margin (%) 15.68
Earnings Per Share (EPS) 26.59
EBITDA 685.80
Effective Tax Rate (%) 22.65
Particulars DEC 2025 (Values in Cr)
Revenue 2363.70
Operating Expense 1958.70
Net Profit 383.50
Net Profit Margin (%) 16.22
Earnings Per Share (EPS) 26.67
EBITDA 690.10
Effective Tax Rate (%) 23.54
Particulars SEP 2025 (Values in Cr)
Revenue 2356.10
Operating Expense 1943.50
Net Profit 419.90
Net Profit Margin (%) 17.82
Earnings Per Share (EPS) 29.20
EBITDA 734.00
Effective Tax Rate (%) 24.16
Particulars JUN 2025 (Values in Cr)
Revenue 2167.90
Operating Expense 1803.80
Net Profit 306.90
Net Profit Margin (%) 14.15
Earnings Per Share (EPS) 21.35
EBITDA 578.60
Effective Tax Rate (%) 22.61
Particulars MAR 2025 (Values in Cr)
Revenue 2075.30
Operating Expense 1746.89
Net Profit 333.40
Net Profit Margin (%) 16.06
Earnings Per Share (EPS) 23.18
EBITDA 612.90
Effective Tax Rate (%) 20.61
Particulars MAR 2026 (Values in Cr)
Revenue 9326.20
Operating Expense 7740.30
Net Profit 1492.60
Net Profit Margin (%) 16.00
Earnings Per Share (EPS) 103.81
EBITDA 2688.40
Effective Tax Rate (%) 23.31
Particulars MAR 2025 (Values in Cr)
Revenue 8202.10
Operating Expense 6861.30
Net Profit 1296.30
Net Profit Margin (%) 15.80
Earnings Per Share (EPS) 90.15
EBITDA 2391.90
Effective Tax Rate (%) 23.22
Particulars MAR 2024 (Values in Cr)
Revenue 7273.80
Operating Expense 6125.10
Net Profit 1010.50
Net Profit Margin (%) 13.89
Earnings Per Share (EPS) 70.28
EBITDA 1977.39
Effective Tax Rate (%) 23.94
Particulars MAR 2023 (Values in Cr)
Revenue 6524.80
Operating Expense 5448.80
Net Profit 1084.80
Net Profit Margin (%) 16.62
Earnings Per Share (EPS) 75.45
EBITDA 1833.00
Effective Tax Rate (%) 11.62
Particulars MAR 2022 (Values in Cr)
Revenue 6098.33
Operating Expense 5286.45
Net Profit 665.03
Net Profit Margin (%) 10.90
Earnings Per Share (EPS) 46.25
EBITDA 1459.59
Effective Tax Rate (%) 32.83
Particulars MAR 2025 (Values in Cr)
Book Value / Share 570.55
ROE % 19.89
ROCE % 17.49
Total Debt to Total Equity 0.61
EBITDA Margin 14.94
Particulars MAR 2024 (Values in Cr)
Book Value / Share 481.75
ROE % 14.26
ROCE % 15.52
Total Debt to Total Equity 0.74
EBITDA Margin 13.21
Particulars MAR 2023 (Values in Cr)
Book Value / Share 430.43
ROE % 15.04
ROCE % 14.16
Total Debt to Total Equity 0.71
EBITDA Margin 12.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 390.51
ROE % 17.26
ROCE % 16.67
Total Debt to Total Equity 0.81
EBITDA Margin 15.29
Particulars MAR 2021 (Values in Cr)
Book Value / Share 319.52
ROE % 2.41
ROCE % 6.47
Total Debt to Total Equity 0.98
EBITDA Margin 11.15
Particulars MAR 2025 (Values in Cr)
Book Value / Share 607.39
ROE % 15.77
ROCE % 17.07
Total Debt to Total Equity 0.38
EBITDA Margin 29.16
Particulars MAR 2024 (Values in Cr)
Book Value / Share 536.22
ROE % 13.81
ROCE % 15.48
Total Debt to Total Equity 0.39
EBITDA Margin 27.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share 481.56
ROE % 16.64
ROCE % 16.00
Total Debt to Total Equity 0.40
EBITDA Margin 28.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 424.94
ROE % 11.56
ROCE % 12.62
Total Debt to Total Equity 0.51
EBITDA Margin 23.68
Particulars MAR 2021 (Values in Cr)
Book Value / Share 361.72
ROE % 2.39
ROCE % 3.62
Total Debt to Total Equity 0.68
EBITDA Margin 15.59
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1360.20
Total Assets 20657.40
Total Liabilities 20657.40
Total Equity 8652.90
Share Outstanding 14
Price to Book Ratio 10.90
Return on Assets (%) 6.99
Return on Capital (%) 10.38
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 933.80
Total Assets 16753.10
Total Liabilities 16753.10
Total Equity 7320.50
Share Outstanding 14
Price to Book Ratio 11.85
Return on Assets (%) 5.36
Return on Capital (%) 8.57
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 775.80
Total Assets 14427.80
Total Liabilities 14427.80
Total Equity 6531.30
Share Outstanding 14
Price to Book Ratio 8.95
Return on Assets (%) 5.67
Return on Capital (%) 8.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 924.00
Total Assets 13269.30
Total Liabilities 13269.30
Total Equity 5903.00
Share Outstanding 14
Price to Book Ratio 10.63
Return on Assets (%) 7.95
Return on Capital (%) 12.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 724.40
Total Assets 11416.70
Total Liabilities 11416.70
Total Equity 4802.40
Share Outstanding 14
Price to Book Ratio 8.03
Return on Assets (%) 1.31
Return on Capital (%) 1.96
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 594.10
Total Assets 13372.30
Total Liabilities 13372.30
Total Equity 8734.20
Share Outstanding 14
Price to Book Ratio 10.90
Return on Assets (%) 9.69
Return on Capital (%) 12.33
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 342.20
Total Assets 12405.20
Total Liabilities 12405.20
Total Equity 7710.90
Share Outstanding 14
Price to Book Ratio 11.85
Return on Assets (%) 8.14
Return on Capital (%) 10.45
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 318.00
Total Assets 10780.40
Total Liabilities 10780.40
Total Equity 6924.80
Share Outstanding 14
Price to Book Ratio 8.95
Return on Assets (%) 10.06
Return on Capital (%) 12.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 556.90
Total Assets 10408.20
Total Liabilities 10408.20
Total Equity 6110.70
Share Outstanding 14
Price to Book Ratio 10.63
Return on Assets (%) 6.39
Return on Capital (%) 8.18
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 408.20
Total Assets 9729.20
Total Liabilities 9729.20
Total Equity 5201.50
Share Outstanding 14
Price to Book Ratio 8.03
Return on Assets (%) 1.07
Return on Capital (%) 1.4
Particulars MAR 2025 (Values in Cr)
Net Income 1505.10
Cash from Operations 2622.40
Cash from Investing -3380.60
Cash from Financing 1316.80
Net change in Cash 72.60
Free Cash Flow 4335.10
Particulars MAR 2024 (Values in Cr)
Net Income 935.00
Cash from Operations 2386.90
Cash from Investing -1537.20
Cash from Financing -311.00
Net change in Cash 72.00
Free Cash Flow 3523.70
Particulars MAR 2023 (Values in Cr)
Net Income 844.30
Cash from Operations 1758.90
Cash from Investing -870.60
Cash from Financing -633.20
Net change in Cash -126.90
Free Cash Flow 2887.40
Particulars MAR 2022 (Values in Cr)
Net Income 1108.40
Cash from Operations 1900.30
Cash from Investing -847.20
Cash from Financing -791.60
Net change in Cash 57.20
Free Cash Flow 2557.50
Particulars MAR 2021 (Values in Cr)
Net Income 136.80
Cash from Operations 1229.30
Cash from Investing -863.40
Cash from Financing -340.10
Net change in Cash 61.10
Free Cash Flow 1524.80
Particulars MAR 2025 (Values in Cr)
Net Income 1296.30
Cash from Operations 2116.90
Cash from Investing -1045.70
Cash from Financing -739.10
Net change in Cash -42.90
Free Cash Flow 2975.10
Particulars MAR 2024 (Values in Cr)
Net Income 1010.50
Cash from Operations 1521.40
Cash from Investing -835.30
Cash from Financing -297.00
Net change in Cash 59.10
Free Cash Flow 2142.40
Particulars MAR 2023 (Values in Cr)
Net Income 1084.80
Cash from Operations 1547.90
Cash from Investing -588.50
Cash from Financing -778.60
Net change in Cash -142.60
Free Cash Flow 1943.90
Particulars MAR 2022 (Values in Cr)
Net Income 665.20
Cash from Operations 1299.40
Cash from Investing -505.30
Cash from Financing -576.60
Net change in Cash 119.00
Free Cash Flow 1823.00
Particulars MAR 2021 (Values in Cr)
Net Income 105.00
Cash from Operations 911.70
Cash from Investing -764.70
Cash from Financing -175.60
Net change in Cash -24.80
Free Cash Flow 1105.90
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
FORTIS MALAR HOSPITALS LIMITED 53.36 24.14 2.91 100.01 40.75 77.00
SHREE PACETRONIX LTD. 130.75 15.60 2.75 49.03 66.10 283.15
TRANSGENE BIOTEK LTD. 3.10 0.00 2.80 23.49 1.83 5.26
VIMTA LABS LTD. 478.55 35.16 6.23 2137.65 377.30 902.85
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 39.30 0.00 -9.56 29.36 30.30 57.48
KOVAI MEDICAL CENTER & HOSPITA 5372.55 24.04 4.45 5877.57 5010.00 6725.00
FORTIS MALAR HOSPITALS LIMITED 53.36 23.82 2.92 100.01 40.75 77.00

APOLLO HOSPITALS ENTER. L shareholding pattern

Holding
6.6%
28.01%
42.61%
22.76%
2.49%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

APOLLO HOSPITALS ENTER. L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
8045.00 -0.78 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 8196.00
  • 26 Days 8023.10
  • 10 Days 8179.90
  • 50 Days 7853.10
  • 12 Days 8162.20
  • 100 Days 7671.50
  • 20 Days 8080.00
  • 200 Days 7505.50
8146.33 PIVOT
First Support 8043.17 First Resistance 8211.67 Second Support 7977.83 Second Resistance 8314.83 Third Support 7874.67 Third Resistance 8380.17
RSI 54.76 ADX 27.22 MACD 139.03 Williams % R -53.22 Commodity Channel Index (CCI) 33.45
Date 2026-06-01 Week 277308.00 Same Day 110259.00 Month 270225.00
1 Year 0.67 3 Year 0.62
Over 1 Month
4.79% down
Over 1 Year
17.25% down
Over 3 Months
4.06% down
Over 3 Years
18.97% down
Over 6 Months
11.26% down
Over 5 Years
20.13% down

APOLLO HOSPITALS ENTER. L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
16 Feb 2026 10.0 Interim 16 Feb 2026 Equity shares
19 Aug 2025 10.0 Final 19 Aug 2025 Equity shares
14 Feb 2025 9.0 Interim 15 Feb 2025 Equity shares
16 Aug 2024 10.0 Final 17 Aug 2024 Equity shares
20 Feb 2024 6.0 Interim 20 Feb 2024 Equity shares
18 Aug 2023 9.0 Final 19 Aug 2023 Equity shares
24 Feb 2023 6.0 Interim 24 Feb 2023 Equity shares
18 Aug 2022 11.75 Final 20 Aug 2022 Equity shares
18 Aug 2021 3.0 Final 21 Aug 2021 Equity shares
17 Sep 2020 2.75 Final 19 Sep 2020 Equity shares
25 Feb 2020 3.25 Interim 26 Feb 2020 Equity shares
12 Sep 2019 6.0 Final 14 Sep 2019 Equity shares
12 Sep 2018 5.0 Final 15 Sep 2018 Equity shares
07 Sep 2017 6.0 Final 09 Sep 2017 Equity shares
22 Mar 2016 6.0 Interim 23 Mar 2016 Equity shares
30 Jul 2015 5.75 Final 01 Aug 2015 Equity shares
13 Aug 2014 5.75 Final 19 Aug 2014 Equity shares
25 Jul 2013 5.5 Final 27 Jul 2013 Equity shares
26 Jul 2012 4.0 Final 28 Jul 2012 Equity shares
07 Jul 2011 3.75 Final 09 Jul 2011 Equity shares
15 Jul 2010 7.0 Final 17 Jul 2010 Equity shares
20 Aug 2009 6.5 Final 22 Aug 2009 Equity shares
11 Aug 2008 6.0 Final 13 Aug 2008 Equity shares
09 Aug 2007 2.0 Final 11 Aug 2007 Equity shares
22 Mar 2007 3.0 Interim 24 Mar 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
02 Sep 2010 10.0 5.0 03 Sep 2010
Dividend date Dividend amount Dividend type Record date Instrument type
16 Feb 2026 10.0 Interim 16 Feb 2026 Equity shares
19 Aug 2025 10.0 Final 19 Aug 2025 Equity shares
14 Feb 2025 9.0 Interim 15 Feb 2025 Equity shares
16 Aug 2024 10.0 Final 17 Aug 2024 Equity shares
20 Feb 2024 6.0 Interim 20 Feb 2024 Equity shares
18 Aug 2023 9.0 Final 19 Aug 2023 Equity shares
24 Feb 2023 6.0 Interim 24 Feb 2023 Equity shares
18 Aug 2022 11.75 Final 20 Aug 2022 Equity shares
18 Aug 2021 3.0 Final 21 Aug 2021 Equity shares
17 Sep 2020 2.75 Final 19 Sep 2020 Equity shares
25 Feb 2020 3.25 Interim 26 Feb 2020 Equity shares
12 Sep 2019 6.0 Final 14 Sep 2019 Equity shares
12 Sep 2018 5.0 Final 15 Sep 2018 Equity shares
07 Sep 2017 6.0 Final 09 Sep 2017 Equity shares
22 Mar 2016 6.0 Interim 23 Mar 2016 Equity shares
30 Jul 2015 5.75 Final 01 Aug 2015 Equity shares
13 Aug 2014 5.75 Final 19 Aug 2014 Equity shares
25 Jul 2013 5.5 Final 27 Jul 2013 Equity shares
26 Jul 2012 4.0 Final 28 Jul 2012 Equity shares
07 Jul 2011 3.75 Final 09 Jul 2011 Equity shares
15 Jul 2010 7.0 Final 17 Jul 2010 Equity shares
20 Aug 2009 6.5 Final 22 Aug 2009 Equity shares
11 Aug 2008 6.0 Final 13 Aug 2008 Equity shares
09 Aug 2007 2.0 Final 11 Aug 2007 Equity shares
22 Mar 2007 3.0 Interim 24 Mar 2007 Equity shares
29 Jul 2005 0.0 Final 02 Aug 2005 Equity shares
Ex-Date Old FV NEW FV Record Date
02 Sep 2010 10.0 5.0 03 Sep 2010

Top Gainers

up-arrow (%)

Top Losers

up-arrow (%)

Apollo Hospitals Enterprise Limited Overview

Apollo Hospitals, founded in 1983 by Dr. Prathap C Reddy, marked the advent of the corporate hospital model in India, leading the private healthcare revolution. It has since established itself as Asia’s leading integrated healthcare services provider, with an extensive presence across the healthcare spectrum, including hospitals, pharmacies, primary care, diagnostic clinics, and various retail health models. As of Q1FY24, Apollo boasts 43 owned and 6 managed hospitals across major urban centres, including Chennai and Hyderabad, offering over 9,500 beds, achieving an occupancy rate of 62%, and an average revenue per occupied bed (ARPOB) of Rs. 57,760. The diagnostics and retail health segment further includes 22 ambulatory care & birthing centres, over 2,000 diagnostics centres, and more than 120 dialysis centres. The digital health and pharmacy distribution network encompasses over 5,600 outlets, with significant growth in the last fiscal year, contributing to a 41% share of the company’s revenue. Notably, Apollo has achieved global recognition in solid multi-organ transplantation, leading with over 23,000 transplants and expanding its robotic colorectal surgery program. The revenue distribution reflects a significant emphasis on healthcare services, contributing 52%, with diagnostics and retail health and digital health & pharma rounding out the financial ecosystem. This comprehensive approach underlines Apollo Hospitals' commitment to innovating and expanding its services, reinforcing its position as a healthcare leader in India and beyond.
 

Apollo Hospitals Share Result Highlights  

Apollo Hospitals Enterprise Ltd. is an Indian healthcare provider and also happens to be the first corporate hospital in India. The company is a huge player in the healthcare industry and provides various services like medical care, diagnostics, and pharmacy services. As of 21 January 2025, 04:01 pm, Apollo Hospitals share price stood at  ₹6919.15 per share.

Apollo Hospitals Share Annual Reports 

According to their Annual Report 2023-24, Apollo Hospital’s operating income fell by 0.2% YoY while its operating profit grew by 55.7% YoY. The net profit of the company also saw a growth of 61.6% YoY and its net profit margins grew from 13.9% in FY23 to 22.5% in FY24.

Apollo Hospitals Share Dividend

The company announced its last dividend in the quarter ending March 2024. The dividend declared stood at ₹10 which translates to a dividend yield of 0.36%.
 

Popular FAQs

  1. Who is the CEO of Apollo Hospitals Enterprise Ltd?

    The CEO of Apollo Hospitals Enterprise Ltd is Dr Madhu Sasidhar.

  2. When was Apollo Hospitals Enterprise Ltd established?

    The company was established on 18 September 1983.

  3. What factors influence the Apollo Hospitals Share Price?

    Factors like the company’s expansion strategy, profit and revenue growth, and international patients have a great impact on the Apollo Hospitals Share Price.

  4. Is Apollo Hospitals Enterprise Ltd debt-free?

    No, the company is not debt-free.

  5. What is the CAGR of Apollo Hospitals Share?

    The company's CAGR for the past 5 years stands between 26.3% and 63.8%.

  6. How has the Apollo Hospitals Share Price performed over the past year?

    Apollo Hospital’s operating income fell by 0.2% YoY, while its operating profit grew by 55.7% YoY. The net profit of the company also saw a growth of 61.6% YoY, and its net profit margins grew from 13.9% in FY23 to 22.5% in FY24.

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Prathap C Reddy Executive Chairman
Preetha Reddy Executive Vice Chairperson
Suneeta Reddy Managing Director
Sangita Reddy Joint Managing Director
Shobana Kamineni Non Executive Director
S M Krishnan Senior Vice President & Company Secretary
Murali Doraiswamy Independent Director
V Kavitha Dutt Independent Director
M B N Rao Lead Independent Director
Som Mittal Independent Director
Rama Bijapurkar Independent Director
Right Arrow

Similar stocks

Left Arrow
similar-logo MAXHEALTH
1.14%
949.15 10.70
down-arrow
similar-logo FORTIS
0.00%
929.15 -0.04
down-arrow
similar-logo NH
1.55%
1934.1 29.59
down-arrow
similar-logo ASTERDM
1.10%
728.95 8.00
down-arrow
similar-logo MEDANTA
2.65%
1199.8 31.00
down-arrow
similar-logo KIMS
-1.10%
745.55 -8.35
down-arrow
similar-logo LALPATHLAB
-0.88%
1563.3 -14.00
down-arrow
similar-logo SYNGENE
-1.59%
440.85 -7.14
down-arrow
similar-logo AGARWALEYE
-0.74%
477.75 -3.60
down-arrow
similar-logo RAINBOW
-1.78%
1345.1 -24.50
down-arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Apollo Hospitals Enterprise Ltd?

Answer Field

Apollo Hospitals Enterprise Ltd share price is for NSE ₹ 8,089.00 & for BSE ₹ 8,085.30 as on Jun 02 2026 03:10 PM.

What is the Market Cap of Apollo Hospitals Enterprise Ltd Share?

Answer Field

The market cap of Apollo Hospitals Enterprise Ltd for NSE ₹ 0.01 & for BSE ₹ 0.01 as on Jun 02 2026 03:10 PM.

What is the 52 Week High and Low of Apollo Hospitals Enterprise Ltd?

Answer Field

The 52 Week High and Low of Apollo Hospitals Enterprise Ltd for NSE is ₹ 8,443.00 and ₹ 6,696.50 and for BSE is ₹ 8,490.30 and ₹ 6,680.00.

What is 1 year return for Apollo Hospitals Enterprise Ltd?

Answer Field

The 1 year returns on the stock has been 17.25%.

What is the P/E Ratio of Apollo Hospitals Enterprise Ltd Share?

Answer Field

As on Jun 02 2026 03:10 PM the price-to-earnings (PE) ratio for Apollo Hospitals Enterprise Ltd share is 78.02.

What is the PB ratio of Apollo Hospitals Enterprise Ltd Share?

Answer Field

As on Jun 02 2026 03:10 PM, the price-to-book (PB) ratio for Apollo Hospitals Enterprise Ltd share is 692.92.

How to Buy Apollo Hospitals Enterprise Ltd Share?

Answer Field

You can trade in Apollo Hospitals Enterprise Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Apollo Hospitals Enterprise Ltd Share on Bajaj Broking App?

Answer Field

To buy Apollo Hospitals Enterprise Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Apollo Hospitals Enterprise Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

Who is the CEO of Apollo Hospitals Enterprise Ltd?

Answer Field

The CEO of Apollo Hospitals Enterprise Ltd is Dr Madhu Sasidhar.

When was Apollo Hospitals Enterprise Ltd established?

Answer Field

The company was established on 18 September 1983.

What factors influence the Apollo Hospitals Share Price?

Answer Field

Factors like the company’s expansion strategy, profit and revenue growth, and international patients have a great impact on the Apollo Hospitals Share Price.

Is Apollo Hospitals Enterprise Ltd debt-free?

Answer Field

No, the company is not debt-free.

What is the CAGR of Apollo Hospitals Share?

Answer Field

The company's CAGR for the past 5 years stands between 26.3% and 63.8%.

How has the Apollo Hospitals Share Price performed over the past year?

Answer Field

Apollo Hospital’s operating income fell by 0.2% YoY, while its operating profit grew by 55.7% YoY. The net profit of the company also saw a growth of 61.6% YoY, and its net profit margins grew from 13.9% in FY23 to 22.5% in FY24.

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Products

arrow

Calculators

arrow

Platforms

arrow

Mutual Funds & SIP

arrow

Important Links

arrow

Explore

arrow

Corporate

arrow

Discover

arrow

Popular Stocks

arrow

Indian Indices

arrow

Global Indices

arrow

Sector Wise Stocks

arrow

IPO

arrow

ATTENTION INVESTORS:

“Investments in securities market are subject to market risk, read all the scheme related documents carefully before investing."

"Prevent Unauthorized transactions in your Trading/Demat Account. Update your mobile numbers/email IDs with your stock brokers/Depository Participant. Receive alerts/information of your transaction/all debit and other important transactions in your Trading/ Demat Account directly from Exchange/CDSL/NSDL at the end of the day. Issued in the interest of investors."

" We collect, retain, and use your contact information for legitimate business purposes only, to contact you and to provide you information & latest updates regarding our products & services."  

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"We understand that certain investment advisors may be approaching members of the public including our clients, representing that they are our partners, or representing that their investment advice is based on our research. Please note that we have not engaged any third parties to render any investment advisory services on our behalf nor are we providing any stock recommendations/tips/research report/advisory. Persons making investments on the basis of such advice may lose all or a part of their investments along with the fee paid to such unscrupulous persons. Please be cautious about any phone call that you may receive from persons representing to be such investment advisors, or a part of research firm offering advice on securities. Do not make payments through e-mail links, WhatsApp or SMS. Please do not share your personal or financial information with any person without proper verification. Always trade through a registered broker."

Bajaj Financial Securities Limited is a subsidiary of Bajaj Finance Limited and is a corporate trading and clearing member of BSE Ltd. and National Stock Exchange of India Ltd. (NSEIL), and also a Depository participant with National Securities Depository Ltd (“NSDL”) and Central Depository Services Ltd. (“CDSL”).

Bajaj Financial Securities Limited is engaged in the business of Stock Broking and as a Depository Participant.Bajaj Financial Securities Limited does not provide any advisory services to its clients. Bajaj Financial Securities Limited may share updates from time to time (through various electronic communication modes) which are sourced from public domain and the same are NOT to be construed as any advice or recommendation from Bajaj Financial Securities Limited. Client is requested to independently evaluate and/or consult their professional advisors before arriving at any conclusion to make any investment. The decision to invest shall be the sole responsibility of the Client and shall not hold Bajaj Financial Securities Limited, its employees and associates responsible for any losses, damages of any type whatsoever.

BSE Ltd. is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time.

BSE Ltd. is not answerable, responsible or liable for any information on this Website or for any services rendered by our employees, our servants, and us.

Personal Loan, Fixed Deposit, EMI Card are provided by Bajaj Finance Limited. Bajaj Financial Securities Limited is only a distributor. These are not exchange traded products and all disputes with respect to the distribution activity, would not have access to exchange investor redressal forum or Arbitration mechanism.

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Please Note:

  1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020

  2. Update your mobile number & email ID with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

  3. Pay 20% upfront margin of the transaction value to trade in cash market segment.

  4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 and BSE vide notice no. 20200731-7 dated July 31, 2020 and 20200831-45 dated August 31, 2020 and other guidelines issued from time to time in this regard.

  5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.

Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in Vernacular Language: BSE | NSE

If the client wishes to revoke /cancel the EDIS mandate placed by them, they can write on email us or call on the toll free number.

Advisory for Investors : NSE | BSE

We also do pro-account trading in Equity & Derivatives Segment.

Filling complaints on SCORES - Easy & Quick

A.  Register on SCORES portal B. Mandatory details for filling complaints on SCORES (i) Name, PAN, Address, Mobile Number, E-mail ID C. Benefits: (i) Effective Communication (ii) Speedy redressal of the grievances.

SEBI Registration No.: INZ000218931 | BSE Cash/CDS/F&O (Member ID: 6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No : IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN – 163403 Research Analyst SEBI Registration No. INH000010043

Compliance officer:

Mr. Boudhayan Ghosh 
TEL: 020-48574486
Email for any investor grievances or write to us for DP related matters.

DISCLAIMER

STANDARD DISCLAIMER

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403. 

Website: Bajaj Broking

RESEARCH DISCLAIMER

Broking services offered by Bajaj Financial Securities Limited | Registered Office: Bajaj Auto Limited Complex , Mumbai –Pune Road Akurdi Pune 411035 | Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014 | CIN: U67120PN2010PLC136026 | Research Analyst SEB I Registration No: INH000010043.

Details of Compliance Officer: 

Mr. Boudhayan Ghosh (For Broking/DP/Research)
Email | Contact No.: 020-4857 4486 

Investment in the securities involves risks, investor should consult his own advisors/consultant to determine the merits and risks of investment.

DISCLOSURES

Disclosures under the provisions of SEBI (Research Analysts) Regulations 2014 (Regulations) 

Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities. There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. This research report has been prepared and distributed byBajaj Financial Securities Limited in the capacity of a Research Analyst as per Regulation 22(1) of SEBI (Research Analysts) Regulations 2014 having SEBI Registration No. INH000010043. 

DISCLAIMER

This e-mail/ short message service (SMS) may contain confidential, proprietary or legally privileged information. It should not be used by anyone who is not the original intended recipient. If you have erroneously received this message, please delete it immediately and notify the sender. The recipient acknowledges thatBajaj Financial Securities Limited or its holding and/or associated companies, as the case may be, are unable to exercise control or ensure or guarantee the integrity of/over the contents of the information contained in e-mail /SMS transmissions and further acknowledges that any views expressed in this message are those of the individual sender and no binding nature of the message shall be implied or assumed unless the sender does so expressly with due authority of Bajaj Financial Securities Limited. This message is not intended as an offer or publication or solicitation for distribution for subscription of or purchase or sale of any securities or financial instrument(s) to anyone in whose jurisdiction such subscription etc. requires prior local regulatory clearance or is contrary to the local laws of the land in any manner or as an official confirmation of any transaction. Before opening any attachments, please check them for viruses and defects. 

This service / information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose unless otherwise expressly authorised. This service / information is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subjectBajaj Financial Securities Limited and affiliates/ group/holding companies to any registration or licensing requirements within such jurisdiction. The distribution of this document in certain jurisdictions may be restricted by law, and persons in whose possession this document comes, should inform themselves about and observe any such restrictions.  

The data would be provided to the clients on an "as is" and "where-is" basis, without any warranty. Bajaj Financial Securities Limited or its subsidiaries and associated companies shall not be liable for any delay or any other interruption which may occur in providing the data due to any reason including network (Internet) reasons or snags in the system, breakdown of the system or any other equipment, server breakdown, maintenance shutdown, breakdown of communication services or inability of the Bajaj Financial Securities Limited or its subsidiaries and associated companies to provide the data. In no event shall the Bajaj Financial Securities Limited or its holding and associated companies be liable for any damages, including without limitation direct or indirect, special, incidental, or consequential damages, losses or expenses arising in connection with the data provided by the Bajaj Financial Securities Limited or its holding and associated companies.

ADDITIONAL DISCLAIMER FOR U.S. PERSONS

Bajaj Financial Securities Limited is not a registered broker-dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition, Bajaj Financial Securities Limited is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for U.S. persons. This email message does not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services and/or shall not be considered as an advertisement tool. "U.S. Persons" are generally defined as a natural person, residing in the United States or any entity organized or incorporated under the laws of the United States. US Citizens living abroad may also be deemed "US Persons" under certain rules.  

ADDITIONAL DISCLAIMER FOR CANADIAN PERSONS

Bajaj Financial Securities Limited is not a registered adviser or dealer under applicable Canadian securities laws nor has it obtained an exemption from the adviser and/or dealer registration requirements under such law. Accordingly, any brokerage and investment services provided by Bajaj Financial Securities Limited, including the products and services described herein are not available to or intended for Canadian persons.  

This mailer and its respective contents do not constitute an offer or invitation to purchase or subscribe for any securities or solicitation of any investments or investment services.  

DISCLAIMER FOR REPORT

DISCLOSURES UNDER THE PROVISIONS OF SEBI (RESEARCH ANALYSTS) REGULATIONS 2014 (REGULATIONS)

Bajaj Financial Securities Limited ("Bajaj Broking" or "Research Entity") is regulated by the Securities and Exchange Board of India ("SEBI") and is licensed to carry on the business of broking, depository services and related activities.  

This Report has been prepared by Bajaj Financial Securities Limited in the capacity of a Research Analyst having SEBI Registration No. INH000010043 and distributed as per SEBI (Research Analysts) Regulations 2014. This report does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. The information contained herein is from publicly available data or other sources believed to be reliable. This report is provided for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such investment. The investment discussed or views expressed may not be suitable for all investors.  

This information is strictly confidential and is being furnished to you solely for your information. This information should not be reproduced or redistributed or passed on directly or indirectly in any form to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Bajaj Financial Securities Limited and associates / group companies to any registration or licensing requirements within such jurisdiction. The distribution of this report in certain jurisdictions may be restricted by law, and persons in whose possession this report comes, should observe, any such restrictions. The information given in this report is as of the date of this report and there can be no assurance that future results or events will be consistent with this information. This information is subject to change without any prior notice. Bajaj Financial Securities Limited reserves the right to make modifications and alterations to this statement as may be required from time to time. Bajaj Financial Securities Limited or any of its associates / group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. Bajaj Financial Securities Limited is committed to providing independent and transparent recommendation to its clients. Neither Bajaj Financial Securities Limited nor any of its associates, group companies, directors, employees, agents or representatives shall be liable for any damages whether direct, indirect, special or consequential including loss of revenue or lost profits that may arise from or in connection with the use of the information. Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. Past performance is not necessarily a guide to future performance .The disclosures of interest statements incorporated in this report are provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The information provided in these reports remains, unless otherwise stated, the copyright of Bajaj Financial Securities Limited. All layout, design, original artwork, concepts and other Intellectual Properties, remains the property and copyright of Bajaj Financial Securities Limited and may not be used in any form or for any purpose whatsoever by any party without the express written permission of the copyright holders.  

We offer our research services to clients as well as our prospects. Though this report is disseminated to all the customers simultaneously, not all customers may receive this report at the same time. We will not treat recipients as customers by virtue of their receiving this report.  

Bajaj Financial Securities Limited and its associates, officer, directors, and employees, research analyst (including relatives) worldwide may: (a) from time to time, have long or short positions in, and buy or sell the securities thereof, of company(ies), mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company/company(ies) discussed herein or act as advisor or lender/borrower to such company(ies) or have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance. Bajaj Financial Securities Limited may have proprietary long/short position in the above-mentioned scrip(s) and therefore should be considered as interested. The views provided herein are general in nature and do not consider risk appetite or investment objective of any particular investor; readers are requested to take independent professional advice before investing. This should not be construed as invitation or solicitation to do business with Bajaj Financial Securities Limited.  

Bajaj Financial Securities Limited or its associates may have received compensation from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have managed or co-managed public offering of securities for the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received compensation for investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates may have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past 12 months. Bajaj Financial Securities Limited or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report. Research analyst or his/her relative or Bajaj Financial Securities Limited’s associates may have financial interest in the subject company. Bajaj Financial Securities Limited, its associates, research analyst and his/her relative may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report or at the time of public appearance.  

Research analyst has served as an officer, director or employee of subject Company: No  

Bajaj Financial Securities Limited has financial interest in the subject companies: No  

Bajaj Financial Securities Limited’s Associates may have actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report.  

Research analyst or his/her relative has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

Bajaj Financial Securities Limited has actual/beneficial ownership of 1% or more securities of the subject company at the end of the month immediately preceding the date of publication of research report: No  

Subject company may have been client during twelve months preceding the date of distribution of the research report.  

There were no instances of non-compliance by Bajaj Financial Securities Limited on any matter related to the capital markets, resulting in significant and material disciplinary action during the last three years. A graph of daily closing prices of the securities is also available at NSE

ANALYST CERTIFICATION

The analyst for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.  

RISK DISCLOSURE ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

BROKERAGE DISCLAIMER

All leveraged intraday positions will be squared off on the same day. There is no restriction on the withdrawal of the unutilised margin amount. Brokerage will not exceed the SEBI prescribed limit. Visit : Pricing

MTF 

As subject to the provisions of SEBI Circular CIR/MRD/DP/54/2017 dated June 13, 2017, and the terms and conditions mentioned in the lights and obligations statement issued by the TM (if applicable).  

US INVESTING

International investment is not supervised by any regulatory body in India. Thus, any claim or dispute relating to such investment or enforcement of any agreement/contract /claim will not be under laws and regulations of the recognized stock exchanges and investor protection under Indian Securities Law. The account opening process will be carried out on Vested platform and Bajaj Financial Securities Limited will not have any role in it.  

IPO 

This should not be construed as soliciting investment. Investors’ discretion is required. Kindly consult your financial expert before investing. No need to issue cheques by investors while subscribing to IPO. Investments in securities markets are subject to market risks, read all the related documents carefully before investing.  

SCREENERS 

Screeners is not Exchange-approved products and any disputes related to the same will not be dealt on the Exchange platform. 

SECURITIES 

Securities quoted are exemplary and not recommendatory. 

IPV 

Account would be open after all procedure relating to IPV and client due diligence is completed. 

IMAGES 

The images used are only for representation purpose. Proper due diligence has been done for the images and the image is not of any artist. The same is captured from royalty free sites.

THIRD PARTY PRODUCT DISCLAIMER

Bajaj Financial Securities Limited is a distributor for Non-Broking Products/Services such as Mutual Funds, Mutual Funds SIP, IPO, Bonds, Insurance, PMS, Global Investing, any other third-party products/services. These are not Exchange Traded Products, and we are only acting as distributors. All disputes with respect to the distribution activity, would not have access to SCORES/ODR, Exchange investor redressal forum or Arbitration mechanism. Please refer to the detailed disclaimer for Third-Party Products.

DISCLOSURE TO CLIENTS REGARDING PAYOUT OF FUNDS

As per SEBI circular no. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/84 dated June 08, 2023, Stockbrokers are required to upstream the entire client funds lying with them to the Clearing Corporation. Based on client’s request the funds’ release request must be placed with the Clearing Corporation. Based on the internal process and cut-off timelines of the Clearing Corporation the funds will be released to the Stock Broker. In view of this new process, as specified by the regulatory and the cut-off time of Clearing Corporation/Banks processing the funds, Bajaj Financial Securities Limited cannot commit the exact time for releasing funds payout to its client. Clients are requested to note that, Bajaj Financial Securities Limited will not be responsible for any inconvenience caused to clients due to delay in release of funds payout, including fines, delayed charges, defaults, etc.